Advertisements



Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results.....»»

Category: topSource: seekingalphaJul 12th, 2018

Biotech Analysis Central Pharma News: Johnson & Johnson"s Partnership, Dynavax"s Advancements, Aveo"s Positive Results

Biotech Analysis Central Pharma News: Johnson & Johnson"s Partnership, Dynavax"s Advancements, Aveo"s Positive Results.....»»

Category: topSource: seekingalphaNov 7th, 2018

Biotech Analysis Central Pharma News: Shire"s Results, Novo Nordisk"s Goal, Pfizer And Exact Team Up

Biotech Analysis Central Pharma News: Shire"s Results, Novo Nordisk"s Goal, Pfizer And Exact Team Up.....»»

Category: topSource: seekingalphaAug 28th, 2018

Biotech Analysis Central Pharma News: Regeneron"s Results, BMY"s Failure, Novartis" FDA Rejection

Biotech Analysis Central Pharma News: Regeneron"s Results, BMY"s Failure, Novartis" FDA Rejection.....»»

Category: topSource: seekingalphaOct 18th, 2018

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light.....»»

Category: topSource: seekingalphaSep 5th, 2018

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure.....»»

Category: topSource: seekingalphaAug 28th, 2018

Biotech Analysis Central Pharma News: Gilead"s Hope Dashed, Pfizer"s Vaccine Deal, Eisai And Merck FDA Approval

Biotech Analysis Central Pharma News: Gilead"s Hope Dashed, Pfizer"s Vaccine Deal, Eisai And Merck FDA Approval.....»»

Category: topSource: seekingalphaAug 20th, 2018

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio"s FDA Despair, Paratek"s Positive FDA Panel

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio"s FDA Despair, Paratek"s Positive FDA Panel.....»»

Category: topSource: seekingalphaAug 13th, 2018

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment.....»»

Category: topSource: seekingalphaAug 6th, 2018

Biotech Analysis Central Pharma News: Teva"s U.S. Erosion, Denali"s Preliminary Results, Epizyme"s Trial Shutdown

Biotech Analysis Central Pharma News: Teva"s U.S. Erosion, Denali"s Preliminary Results, Epizyme"s Trial Shutdown.....»»

Category: topSource: seekingalphaAug 3rd, 2018

Biotech Analysis Central Pharma News: Merck"s HIV Results, Biogen"s Partnership, Eli Lilly"s $1 Billion Deal

Biotech Analysis Central Pharma News: Merck"s HIV Results, Biogen"s Partnership, Eli Lilly"s $1 Billion Deal.....»»

Category: topSource: seekingalphaJul 31st, 2018

Biotech Analysis Central Pharma News: Merck Notches A Win, resTORbio"s Positive Phase 2b, Abbvie"s Endometriosis Pain Drug Approval

Biotech Analysis Central Pharma News: Merck Notches A Win, resTORbio"s Positive Phase 2b, Abbvie"s Endometriosis Pain Drug Approval.....»»

Category: topSource: seekingalphaJul 28th, 2018

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Category: topSource: seekingalphaJun 6th, 2018

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Voyager"s Update, Sarepta"s Raise, Nektar"s Struggle

Biotech Analysis Central Pharma News: Voyager"s Update, Sarepta"s Raise, Nektar"s Struggle.....»»

Category: topSource: seekingalphaNov 13th, 2018

Biotech Analysis Central Pharma News: Roche"s Deal, AcelRX Panel Vote, Crispr And Vertex Hold Removal

Biotech Analysis Central Pharma News: Roche"s Deal, AcelRX Panel Vote, Crispr And Vertex Hold Removal.....»»

Category: topSource: seekingalphaOct 17th, 2018

Biotech Analysis Central Pharma News: Menlo"s Failure, Trevena"s Documents, Affimed Halts Studies

Biotech Analysis Central Pharma News: Menlo"s Failure, Trevena"s Documents, Affimed Halts Studies.....»»

Category: topSource: seekingalphaOct 10th, 2018

Biotech Analysis Central Pharma News: Gilead"s New Move, Sarepta"s Hold Removal, Alexion"s Plan

Biotech Analysis Central Pharma News: Gilead"s New Move, Sarepta"s Hold Removal, Alexion"s Plan.....»»

Category: topSource: seekingalphaSep 26th, 2018

Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win

Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win.....»»

Category: topSource: seekingalphaAug 24th, 2018

Biotech Analysis Central Pharma News: Regeneron"s Reversal Of Fortune, Bristol-Myers Squibb"s FDA Win, Novo Nordisk"s Acquisition

Biotech Analysis Central Pharma News: Regeneron"s Reversal Of Fortune, Bristol-Myers Squibb"s FDA Win, Novo Nordisk"s Acquisition.....»»

Category: topSource: seekingalphaAug 20th, 2018